Diagnostic accuracy of American College of Radiology Thyroid Imaging Reporting and Data System for malignancy risk stratification in thyroid nodules: Correlation with fine-needle aspiration cytology in a retrospective observational study
Journal of Indira Gandhi Institute of Medical Sciences · 2026
DOI: 10.4103/jigims.jigims_14_26 ↗Abstract
Background: Thyroid nodules are frequently encountered in clinical practice, and their detection has risen with the widespread use of high-resolution ultrasonography. Most are benign, yet a clinically meaningful proportion harbor malignancy, making accurate risk stratification necessary; ultrasonography enables this evaluation through detailed morphological characterization. The American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) standardizes ultrasound reporting and stratifies nodules by malignancy risk, while fine-needle aspiration cytology (FNAC), reported using the Bethesda System, remains the cytological reference standard. Objective: To assess the diagnostic accuracy of ACR TI-RADS for predicting malignancy in thyroid nodules through correlation of ultrasound findings with FNAC outcomes. Materials and Methods: In this retrospective observational study, 164 patients with thyroid nodules underwent both ultrasonography and FNAC between April 2024 and December 2025. Ultrasound assessment was performed using a high-frequency linear transducer, with each nodule classified according to ACR TI-RADS; FNAC results were interpreted using the Bethesda system. Referral for FNAC generally followed ACR TI-RADS size-based criteria, although a subset of nodules underwent biopsy based on additional clinical factors and clinician discretion. Diagnostic performance was characterized using sensitivity, specificity, positive and negative predictive values (NPV), and overall accuracy. Results: Of the 164 patients, 146 were female and 18 were male; TR3 was the most frequent ultrasound category (74 nodules), followed by TR2 (53), TR4 (22), TR1 (11), and TR5 (4). FNAC showed 118 benign, 9 cytologically positive (surgical-risk), and 37 indeterminate cases. After excluding indeterminate cases, sensitivity was 88.9%, specificity 92.4%, positive predictive value 47.1%, NPV 99.1%, and accuracy 92.1%. Area under the curve was 0.945 in receiver operating characteristic analysis. Conclusion: ACR TI-RADS demonstrated a high NPV (99.1%), supporting its potential utility in identifying low-risk thyroid nodules and safely deferring unnecessary invasive procedures. The apparent sensitivity of 88.9% should be interpreted cautiously given the small number of cytologically positive (surgical-risk) cases ( n = 9) and the resultant wide 95% confidence interval (51.8%-99.7%). ACR TI-RADS shows promise as a risk stratification tool; however, prospective validation with larger cytologically positive (surgical-risk) cohorts is warranted before definitive claims regarding sensitivity can be made.
EUVIMED